Curiox Biosystems Co., Ltd (KOSDAQ: 445680)
South Korea flag South Korea · Delayed Price · Currency is KRW
18,520
-190 (-1.02%)
Dec 20, 2024, 9:00 AM KST

Curiox Biosystems Statistics

Total Valuation

Curiox Biosystems has a market cap or net worth of KRW 298.11 billion. The enterprise value is 275.81 billion.

Market Cap 298.11B
Enterprise Value 275.81B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date Mar 21, 2025
Ex-Dividend Date n/a

Share Statistics

Curiox Biosystems has 16.10 million shares outstanding. The number of shares has increased by 28.47% in one year.

Current Share Class n/a
Shares Outstanding 16.10M
Shares Change (YoY) +28.47%
Shares Change (QoQ) +0.13%
Owned by Insiders (%) 17.76%
Owned by Institutions (%) 14.02%
Float 11.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 49.81
PB Ratio 6.53
P/TBV Ratio 26.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -22.29
EV / Sales 46.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -27.02

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.17.

Current Ratio 1.44
Quick Ratio 1.26
Debt / Equity 0.17
Debt / EBITDA n/a
Debt / FCF -0.76
Interest Coverage -39.91

Financial Efficiency

Return on equity (ROE) is -24.46% and return on invested capital (ROIC) is -13.93%.

Return on Equity (ROE) -24.46%
Return on Assets (ROA) -11.59%
Return on Capital (ROIC) -13.93%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.09
Inventory Turnover 1.46

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -11.91% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -11.91%
50-Day Moving Average 20,994.80
200-Day Moving Average 22,263.05
Relative Strength Index (RSI) 44.02
Average Volume (20 Days) 159,665

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Curiox Biosystems had revenue of KRW 5.97 billion and -12.37 billion in losses. Loss per share was -770.97.

Revenue 5.97B
Gross Profit 3.12B
Operating Income -12.20B
Pretax Income -12.31B
Net Income -12.37B
EBITDA -10.09B
EBIT -12.20B
Loss Per Share -770.97
Full Income Statement

Balance Sheet

The company has 30.06 billion in cash and 7.76 billion in debt, giving a net cash position of 22.31 billion or 1,385.83 per share.

Cash & Cash Equivalents 30.06B
Total Debt 7.76B
Net Cash 22.31B
Net Cash Per Share 1,385.83
Equity (Book Value) 45.66B
Book Value Per Share 2,836.14
Working Capital 10.74B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.16 billion and capital expenditures -49.29 million, giving a free cash flow of -10.21 billion.

Operating Cash Flow -10.16B
Capital Expenditures -49.29M
Free Cash Flow -10.21B
FCF Per Share -634.21
Full Cash Flow Statement

Margins

Gross margin is 52.24%, with operating and profit margins of -204.45% and -207.35%.

Gross Margin 52.24%
Operating Margin -204.45%
Pretax Margin -206.23%
Profit Margin -207.35%
EBITDA Margin -169.08%
EBIT Margin -204.45%
FCF Margin n/a

Dividends & Yields

Curiox Biosystems does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -28.47%
Shareholder Yield -28.47%
Earnings Yield -4.16%
FCF Yield -3.42%

Stock Splits

The last stock split was on August 6, 2024. It was a forward split with a ratio of 2.

Last Split Date Aug 6, 2024
Split Type Forward
Split Ratio 2

Scores

Curiox Biosystems has an Altman Z-Score of 6.34.

Altman Z-Score 6.34
Piotroski F-Score n/a